Tribunal rulings on assessment order defects, deductions, and transfer pricing adjustments

The Tribunal dismissed the jurisdictional defect in the assessment order on a dissolved/amalgamating company as infructuous. It held that no separate adjudication was required for general and consequential issues. Additionally, the Tribunal dismissed the validity of the assessment order passed under section 143(3) r.w.s. 144C on similar grounds. Regarding various disallowances and deductions, the Tribunal allowed deductions for contributions to certain entities, payments made to pharmaceutical companies, and employee compensation expenses. It directed the deletion of additional disallowances and additions made by the Assessing Officer. The Tribunal also directed fresh adjudication on certain transfer pricing adjustments and other disallowances, following precedents and specific case laws.

---

---

Issues Involved:
1. Jurisdictional defect in assessment order on a dissolved/amalgamating company.
2. Validity of assessment order passed under section 143(3) r.w.s. 144C.
3. Transfer Pricing adjustments and selection of tested party.
4. Disallowance under section 14A read with Rule 8D.
5. Addition of disallowed expenses under section 14A in computing book profit under section 115JB.
6. Disallowance of deduction under section 35(2AB).
7. Disallowance of contributions to Ranbaxy Community Healthcare Society and Ranbaxy Science Foundation.
8. Disallowance of deduction under sections 80-IB and 80-IC.
9. Disallowance of amounts paid to Teva Pharmaceutical Industries Limited.
10. Disallowance of amounts paid to US FDA.
11. Addition of amounts paid to US FDA while computing book profit under section 115JB.
12. Disallowance of expenditure incurred for doctors for promotion of business.
13. Disallowance of Mark to Market Loss.
14. Disallowance of hedging charges treating it as capital loss.
15. Non-allowance of Interest Rate Swap as revenue expenditure.
16. Non-allowance of weighted deduction under section 35(2AB) on cost of assets incurred.
17. Non-allowance of deduction of employee compensation (ESOP) expenses under section 37(1).
18. Computation of interest under sections 234B and 234C.
19. Initiation of penalty proceedings under section 271(1)(c).

Detailed Analysis:

1. Jurisdictional Defect in Assessment Order on a Dissolved/Amalgamating Company:
The Tribunal dismissed the ground as infructuous, holding that no separate adjudication is required for general and consequential issues.

2. Validity of Assessment Order Passed Under Section 143(3) r.w.s. 144C:
The Tribunal dismissed the ground as infructuous, holding that no separate adjudication is required for general and consequential issues.

3. Transfer Pricing Adjustments and Selection of Tested Party:
The Tribunal held that the assessee's AEs should be accepted as the tested party, being the least complex for comparability analysis of international transactions. This decision was based on the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09. The Tribunal restored the issue to the TPO for fresh adjudication, considering the AEs as the tested party.

4. Disallowance Under Section 14A Read with Rule 8D:
The Tribunal held that no further disallowance under section 14A can be imputed beyond what the assessee had already disallowed. The AO did not record satisfaction regarding the correctness of the assessee's disallowance, which is a prerequisite for invoking Rule 8D. The Tribunal directed the AO to delete the additional disallowance made under section 14A.

5. Addition of Disallowed Expenses Under Section 14A in Computing Book Profit Under Section 115JB:
The Tribunal held that no addition under section 115JB is warranted for the amount disallowed under section 14A. This decision was based on the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09. The Tribunal directed the AO to exclude the amount of disallowance under section 14A while computing the book profit under section 115JB.

6. Disallowance of Deduction Under Section 35(2AB):
The Tribunal allowed the deduction claimed by the assessee under section 35(2AB), holding that the furnishing of Form No. 3CM was sufficient for claiming the deduction. The Tribunal followed its own decision in the assessee's case for AY 2009-10, which was upheld by the Hon’ble Gujarat High Court.

7. Disallowance of Contributions to Ranbaxy Community Healthcare Society and Ranbaxy Science Foundation:
The Tribunal allowed the deduction, holding that the contributions were made in furtherance of business objectives and had been decided in the assessee's favor in earlier years by the Delhi High Court. The Tribunal also held that there was no requirement to deduct tax at source on these payments.

8. Disallowance of Deduction Under Sections 80-IB and 80-IC:
The Tribunal allowed the deduction, holding that the issue was covered by the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09. The Tribunal noted that the deduction had been allowed in earlier years and there was no change in facts or law.

9. Disallowance of Amounts Paid to Teva Pharmaceutical Industries Limited:
The Tribunal allowed the deduction, holding that the payment was made as a matter of commercial expediency and was wholly and exclusively for the purpose of the business. The Tribunal also noted that the TPO had treated the payment as an operating expenditure.

10. Disallowance of Amounts Paid to US FDA:
The Tribunal allowed the deduction, holding that the payment was made to resolve an ongoing litigation and was not an offense or prohibited by law. The Tribunal also noted that the liability had crystallized in the year under consideration.

11. Addition of Amounts Paid to US FDA While Computing Book Profit Under Section 115JB:
The Tribunal directed the AO to delete the disallowance made under section 115JB, holding that the liability had crystallized in the year under consideration.

12. Disallowance of Expenditure Incurred for Doctors for Promotion of Business:
The Tribunal allowed the deduction, holding that the Medical Council of India regulations were not applicable to pharmaceutical companies and the CBDT circular was not applicable for the year under consideration.

13. Disallowance of Mark to Market Loss:
The Tribunal dismissed the ground as not pressed by the assessee.

14. Disallowance of Hedging Charges Treating It as Capital Loss:
The Tribunal restored the issue to the AO for fresh adjudication, following the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09.

15. Non-Allowance of Interest Rate Swap as Revenue Expenditure:
The Tribunal restored the issue to the AO for fresh adjudication, following the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09.

16. Non-Allowance of Weighted Deduction Under Section 35(2AB) on Cost of Assets Incurred:
The Tribunal restored the issue to the AO for fresh adjudication, following the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09.

17. Non-Allowance of Deduction of Employee Compensation (ESOP) Expenses Under Section 37(1):
The Tribunal allowed the deduction, following the ITAT Delhi Bench's order in the assessee's own case for AY 2008-09, holding that the ESOP expenses were an ascertained liability and allowable as revenue expenditure.

18. Computation of Interest Under Sections 234B and 234C:
The Tribunal did not specifically address this issue in the detailed analysis.

19. Initiation of Penalty Proceedings Under Section 271(1)(c):
The Tribunal did not specifically address this issue in the detailed analysis.

---